Topical Wound Agents Market Share

  • Report ID: 4569
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Topical Wound Agents Market Share

The North America topical wound agents market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market in the region can be accounted to the rising prevalence of chronic wounds and rising healthcare expenditure. It became quite convenient for people to receive quick treatment since the developed health expenditure of multiple nations is providing the necessary workforce and medicines. As per the data provided by the Centers for Medicare & Medicaid Services, the national health expenditure of the United States is expected to rise by 5.1% per year between 2021 and 2030, reaching nearly USD 6.8 trillion. Further, the presence of a strong healthcare network in the region, along with the availability of skilled medical professionals to use topical wound agents are also anticipated to contribute to the market growth in the region. In addition, the rising cases of chronic diseases, especially diabetes, are also expected to surge the growth of the North America market in the analysis period.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4569
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of topical wound agents is assessed at USD 2.56 billion.

The topical wound agents market size was over USD 2.39 billion in 2024 and is projected to reach USD 7.15 billion by 2037, growing at around 8.8% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of chronic wounds, the increasing number of diabetic foot ulcers, the surge in burns cases, and the escalation in post-surgical wounds will drive the market growth.

North America industry is poised to account for largest revenue share of 40% by 2037, due to rising prevalence of chronic wounds and rising healthcare expenditure.

The major players in the market include Smith & Nephew PLC, Mölnlycke Health Care AB, Novartis Pharma AG, Pfizer Inc., Johnson & Johnson Services, Inc., Viatris Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Coloplast A/S, ConvaTec Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample